CP Denton

2.0k total citations · 1 hit paper
33 papers, 1.3k citations indexed

About

CP Denton is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and General Health Professions. According to data from OpenAlex, CP Denton has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 11 papers in Pulmonary and Respiratory Medicine and 5 papers in General Health Professions. Recurrent topics in CP Denton's work include Systemic Sclerosis and Related Diseases (20 papers), Pulmonary Hypertension Research and Treatments (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). CP Denton is often cited by papers focused on Systemic Sclerosis and Related Diseases (20 papers), Pulmonary Hypertension Research and Treatments (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). CP Denton collaborates with scholars based in United Kingdom, United States and Switzerland. CP Denton's co-authors include C. M. Black, C Knight, Joseph Davar, Bernard Coleiro, Deepa George, D Mukerjee, Gerry Coghlan, James R. Seibold, Marco Matucci‐Cerinic and C. M. Black and has published in prestigious journals such as Critical Care Medicine, Annals of the Rheumatic Diseases and European Respiratory Journal.

In The Last Decade

CP Denton

30 papers receiving 1.3k citations

Hit Papers

Prevalence and outcome in systemic sclerosis associated p... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers

CP Denton
Joanne Sahhar Australia
CP Denton
Citations per year, relative to CP Denton CP Denton (= 1×) peers Joanne Sahhar

Countries citing papers authored by CP Denton

Since Specialization
Citations

This map shows the geographic impact of CP Denton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CP Denton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CP Denton more than expected).

Fields of papers citing papers by CP Denton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CP Denton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CP Denton. The network helps show where CP Denton may publish in the future.

Co-authorship network of co-authors of CP Denton

This figure shows the co-authorship network connecting the top 25 collaborators of CP Denton. A scholar is included among the top collaborators of CP Denton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CP Denton. CP Denton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leaphart, Cynthia L. & CP Denton. (2025). 976: PERIOPERATIVE ANTIBIOTICS: IS DRUG-INDUCED HYPERSENSITIVITY PNEUMONITIS AN ALLERGIC RESPONSE?. Critical Care Medicine. 53(1).
2.
Donato, Stefano Di, Mary K. Hughes, CP Denton, et al.. (2024). OP0093 TOWARDS A UNIFIED VASCULAR ENDOTYPE IN SYSTEMIC SCLEROSIS. PROGNOSTIC VALUE OF VASCULAR DISEASE IN THE EUSTAR DATABASE. Annals of the Rheumatic Diseases. 83. 71–72. 1 indexed citations
3.
Ong, et al.. (2017). UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis.. PubMed. 34 Suppl 100(5). 106–109. 28 indexed citations
4.
Agueusop, Inoncent, Stéphane Illiano, Corinne Rocher, et al.. (2017). OP0339 Identification of a transcriptomic signature correlated with modified rodnan skin score (MRSS) in patients with diffuse cutaneous systemic sclerosis. Annals of the Rheumatic Diseases. 76. 195–196. 1 indexed citations
5.
Feeney, Maria, Farhan Syed, Khaleque Newaz Khan, et al.. (2015). Oncostatin M As a Potential Molecular Target in Systemic Sclerosis. UCL Discovery (University College London). 4 indexed citations
6.
Khanna, Dinesh, et al.. (2014). SAR100842, an Antagonist of Lysophaphatidic Acid Receptor 1, As a Potential Treatment for Patients with Systemic Sclerosis: Results from a Phase 2a Study.. UCL Discovery (University College London). 3 indexed citations
7.
Trinder, Sarah L., et al.. (2014). Dysfunctional Endothelial Progenitor Cells may Contribute to Vasculopathy in Systemic Sclerosis. European Journal of Vascular and Endovascular Surgery. 47(6). 694–694. 1 indexed citations
8.
Jones, Hefin, Isabel R. Orriss, Timothy R. Arnett, et al.. (2014). Fibrillin-1 expression, which regulates of TGF-B bioavailability, is modified during osteoarthritis and mutations lead to osteoarthritis. Osteoarthritis and Cartilage. 22. S141–S141. 2 indexed citations
9.
Sobanski, Vincent, et al.. (2013). Scleroderma Renal Crisis and Pulmonary Arterial Hypertension Are Very Rare In The Same Patient. UCL Discovery (University College London). 1 indexed citations
10.
Parker, Laura, et al.. (2012). The Impact of Sexual Difficulties in Women with Scleroderma and Interpersonal Relationships. UCL Discovery (University College London). 1 indexed citations
11.
Guo, Feng, et al.. (2012). TAK1 EXPRESSION BY FIBROBLASTS IS REQUIRED FOR FIBROGENIC RESPONSES IN VIVO AND IN VITRO. UCL Discovery (University College London).
12.
Dooley, Audrey, et al.. (2010). AORTIC SMOOTH MUSCLE CELLS SHOW A PRO-FIBROTIC PHENOTYPE IN A TGF-BETA DEPENDENT MOUSE MODEL OF SYSTEMIC SCLEROSIS. UCL Discovery (University College London). 2 indexed citations
13.
Avouac, Jérôme, Otylia Kowal‐Bielecka, David Pittrow, et al.. (2010). Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group. Annals of the Rheumatic Diseases. 69(7). 1360–1363. 32 indexed citations
14.
Goh, Nicole, Sujal R. Desai, Constantinos Anagnostopoulos, et al.. (2010). Increased epithelial permeability in pulmonary fibrosis in relation to disease progression. European Respiratory Journal. 38(1). 184–190. 32 indexed citations
15.
Matucci‐Cerinic, Marco, CP Denton, D.E. Furst, et al.. (2010). Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Annals of the Rheumatic Diseases. 70(1). 32–38. 322 indexed citations
16.
Beirne, Paul, P. Pantelidis, P. Charles, et al.. (2009). Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis. European Respiratory Journal. 34(6). 1376–1382. 55 indexed citations
17.
Black, C. M., et al.. (2007). Using a self-reported functional score to assess disease progression in systemic sclerosis. Lara D. Veeken. 46(7). 1107–1110. 14 indexed citations
18.
Nair, Devika, et al.. (2005). Value of brain natriuretic peptide in pulmonary arterial hypertension. UCL Discovery (University College London). 1 indexed citations
19.
Xu, Shiwen, et al.. (2004). ENDOTHELIN-1 PROMOTES MYOFIBROBLAST INDUCTION THROUGH THE ETA RECEPTOR VIA RAC/PI3 KINASE/AKT AND CONTRIBUTES TO THE CONTRACTILE PHENOTYPE OF SCLERODERMA FIBROBLASTS. UCL Discovery (University College London). 1 indexed citations
20.
Mukerjee, D, Deepa George, Bernard Coleiro, et al.. (2003). Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Annals of the Rheumatic Diseases. 62(11). 1088–1093. 543 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026